HEADER SIGNALING PROTEIN RECEPTOR 15-NOV-05 2F1U TITLE A HOMOLOGY-BASED 3D MODEL OF THE HUMAN NEUROPEPTIDE Y TITLE 2 RECEPTOR Y1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NEUROPEPTIDE Y RECEPTOR TYPE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: NPY1-R; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: NEUROPEPTIDE Y RECEPTOR TYPE 1; COMPND 7 CHAIN: B; COMPND 8 SYNONYM: NPY1-R; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: NEUROPEPTIDE Y RECEPTOR TYPE 1; COMPND 11 CHAIN: C; COMPND 12 SYNONYM: NPY1-R; COMPND 13 MOL_ID: 4; COMPND 14 MOLECULE: NEUROPEPTIDE Y RECEPTOR TYPE 1; COMPND 15 CHAIN: D; COMPND 16 SYNONYM: NPY1-R; COMPND 17 MOL_ID: 5; COMPND 18 MOLECULE: NEUROPEPTIDE Y RECEPTOR TYPE 1; COMPND 19 CHAIN: E; COMPND 20 SYNONYM: NPY1-R; COMPND 21 MOL_ID: 6; COMPND 22 MOLECULE: NEUROPEPTIDE Y RECEPTOR TYPE 1; COMPND 23 CHAIN: F; COMPND 24 SYNONYM: NPY1-R; COMPND 25 MOL_ID: 7; COMPND 26 MOLECULE: NEUROPEPTIDE Y RECEPTOR TYPE 1; COMPND 27 CHAIN: G; COMPND 28 SYNONYM: NPY1-R SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 MOL_ID: 2; SOURCE 5 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 6 ORGANISM_COMMON: HUMAN; SOURCE 7 MOL_ID: 3; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 MOL_ID: 4; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 MOL_ID: 5; SOURCE 14 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 15 ORGANISM_COMMON: HUMAN; SOURCE 16 MOL_ID: 6; SOURCE 17 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 18 ORGANISM_COMMON: HUMAN; SOURCE 19 MOL_ID: 7; SOURCE 20 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 21 ORGANISM_COMMON: HUMAN KEYWDS TRANSMEMBRANE, ALPHA-HELIX, GPCR, EXPDTA THEORETICAL MODEL AUTHOR P.SJODIN,H.AKERBERG,D.LARHAMMAR REVDAT 1 04-JUL-06 2F1U 0 JRNL AUTH P.SJODIN,S.K.S.HOLMBERG,H.AKERBERG,M.M.BERGLUND, JRNL AUTH 2 N.MOHELL,D.LARHAMMAR JRNL TITL RE-EVALUATION OF RECEPTOR-LIGAND INTERACTIONS OF JRNL TITL 2 THE HUMAN NEUROPEPTIDE Y RECEPTOR Y1: A JRNL TITL 3 SITE-DIRECTED MUTAGENESIS STUDY JRNL REF BIOCHEM.J. V. 393 161 2006 JRNL REFN ASTM BIJOAK UK ISSN 0264-6021 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SYBYL (SUBROUTINE POWELL) REMARK 3 AUTHORS : TRIPOS (MUNICH, GERMANY) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: SEVEN RESIDUES CONSERVED AMONG THE REMARK 3 GPCR FAMILY WERE TETHERED BY CONSTRAINTS TO EACH OTHER IN THE REMARK 3 RHODOPSIN TEMPLATE. MODELLING WAS PERFORMED WITH SYBYL 6.9.1 REMARK 3 SOFTWARE RUNNING ON FEDORA CORE 2 LINUX KERNEL 2 USING THE REMARK 3 SUBROUTINE POWELL TO ENERGY-REFINE THE MODEL. THE WHOLE MODEL REMARK 3 WAS MINIMIZED WITH THE KOLLMAN UNITED FORCE FIELD. THE WHAT IF REMARK 3 V.4.99 PROGRAM AND THE RAMACHANDRAN PLOT OF THE RAMPAGE REMARK 3 PROGRAM WERE USED TO EVALUATE THE MODEL. REMARK 4 REMARK 4 2F1U COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-JAN-2006. REMARK 100 THE RCSB ID CODE IS RCSB035347. REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: THE HIGH-RESOLUTION (2.8 A) X-RAY CRYSTALLOGRAPHIC REMARK 220 STRUCTURE OF BOVINE RHODOPSIN WAS USED AS TEMPLATE REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS. DBREF 2F1U A 35 64 UNP P25929 NPY1R_HUMAN 38 67 DBREF 2F1U B 71 100 UNP P25929 NPY1R_HUMAN 74 103 DBREF 2F1U C 107 139 UNP P25929 NPY1R_HUMAN 110 142 DBREF 2F1U D 151 173 UNP P25929 NPY1R_HUMAN 153 175 DBREF 2F1U E 200 225 UNP P25929 NPY1R_HUMAN 208 233 DBREF 2F1U F 247 277 UNP P25929 NPY1R_HUMAN 258 288 DBREF 2F1U G 286 306 UNP P25929 NPY1R_HUMAN 300 320 SEQRES 1 A 30 ALA MET ILE PHE THR LEU ALA LEU ALA TYR GLY ALA VAL SEQRES 2 A 30 ILE ILE LEU GLY VAL SER GLY ASN LEU ALA LEU ILE ILE SEQRES 3 A 30 ILE ILE LEU LYS SEQRES 1 B 30 VAL THR ASN ILE LEU ILE VAL ASN LEU SER PHE SER ASP SEQRES 2 B 30 LEU LEU VAL ALA ILE MET CYS LEU PRO PHE THR PHE VAL SEQRES 3 B 30 TYR THR LEU MET SEQRES 1 C 33 GLU ALA MET CYS LYS LEU ASN PRO PHE VAL GLN CYS VAL SEQRES 2 C 33 SER ILE THR VAL SER ILE PHE SER LEU VAL LEU ILE ALA SEQRES 3 C 33 VAL GLU ARG HIS GLN LEU ILE SEQRES 1 D 23 ARG HIS ALA TYR VAL GLY ILE ALA VAL ILE TRP VAL LEU SEQRES 2 D 23 ALA VAL ALA SER SER LEU PRO PHE LEU ILE SEQRES 1 E 26 ARG LEU SER TYR THR THR LEU LEU LEU VAL LEU GLN TYR SEQRES 2 E 26 PHE GLY PRO LEU CYS PHE ILE PHE ILE CYS TYR PHE LYS SEQRES 1 F 31 THR LYS ARG ILE ASN ILE MET LEU LEU SER ILE VAL VAL SEQRES 2 F 31 ALA PHE ALA VAL CYS TRP LEU PRO LEU THR ILE PHE ASN SEQRES 3 F 31 THR VAL PHE ASP TRP SEQRES 1 G 21 LEU LEU PHE LEU LEU CYS HIS LEU THR ALA MET ILE SER SEQRES 2 G 21 THR CYS VAL ASN PRO ILE PHE TYR HELIX 1 1 ALA A 35 LYS A 64 1 30 HELIX 2 2 VAL B 71 MET B 89 1 19 HELIX 3 3 MET B 89 MET B 100 1 12 HELIX 4 4 GLU C 107 ILE C 139 1 33 HELIX 5 5 ARG D 151 ILE D 173 1 23 HELIX 6 6 ARG E 200 TYR E 212 1 13 HELIX 7 7 TYR E 212 LYS E 225 1 14 HELIX 8 8 THR F 247 TRP F 277 1 31 HELIX 9 9 LEU G 286 MET G 296 1 11 HELIX 10 10 ILE G 297 TYR G 306 1 10 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MASTER 32 0 0 10 0 0 0 6 0 0 0 18 END